Market Analysis and Insights: Global Diagnostic Radiopharmaceuticals & Contrast Media Market
The global Diagnostic Radiopharmaceuticals & Contrast Media market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Radiopharmaceuticals & Contrast Media market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Radiopharmaceuticals & Contrast Media market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Radiopharmaceuticals & Contrast Media market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Radiopharmaceuticals & Contrast Media market.
Global Diagnostic Radiopharmaceuticals & Contrast Media Scope and Market Size
The research report includes specific segments by region (country),
by company,
by Type and
by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2018 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Radiopharmaceuticals
Contrast Media
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amag Pharmaceuticals
Bayer Healthcare
Bracco Imaging
Daiichi Sankyo
GE Healthcare
Guerbet
Lantheus
Mallinckrodt
Medtronic
Nordion
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Diagnostic Radiopharmaceuticals & Contrast Media product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, with price, sales, revenue, and global market share of Diagnostic Radiopharmaceuticals & Contrast Media from 2019 to 2022.
Chapter 3, the Diagnostic Radiopharmaceuticals & Contrast Media competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Radiopharmaceuticals & Contrast Media breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Diagnostic Radiopharmaceuticals & Contrast Media market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Diagnostic Radiopharmaceuticals & Contrast Media.
Chapter 13, 14, and 15, to describe Diagnostic Radiopharmaceuticals & Contrast Media sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Diagnostic Radiopharmaceuticals & Contrast Media Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
TABLE OF CONTENTS
1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Comparison by Application: (2023-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2018-2030
1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2018-2030
1.4.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2018 Versus 2022 Versus 2030
2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2018-2023)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
2.5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2018-2023)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2018-2023)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2018-2023)
5 Global Diagnostic Radiopharmaceuticals & Contrast Media Historic Market Analysis by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2018-2023)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2018-2023)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Amag Pharmaceuticals
6.1.1 Amag Pharmaceuticals Corporation Information
6.1.2 Amag Pharmaceuticals Description and Business Overview
6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.1.5 Amag Pharmaceuticals Recent Developments/Updates
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Corporation Information
6.2.2 Bayer Healthcare Description and Business Overview
6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.2.5 Bayer Healthcare Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Guerbet
6.6.1 Guerbet Corporation Information
6.6.2 Guerbet Description and Business Overview
6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.6.5 Guerbet Recent Developments/Updates
6.7 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Nordion
6.10.1 Nordion Corporation Information
6.10.2 Nordion Description and Business Overview
6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.10.5 Nordion Recent Developments/Updates
7 Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Cost Analysis
7.1 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
7.4 Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
8.3 Diagnostic Radiopharmaceuticals & Contrast Media Customers
9 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics
9.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
9.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
9.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
9.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
10 Global Market Forecast
10.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2023-2030)
10.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2023-2030)
10.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals & Contrast Media by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region (US$ Million) (2018 VS 2022 VS 2030)
Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation by Manufacturers in 2022
Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Diagnostic Radiopharmaceuticals & Contrast Media Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Manufacturing Sites and Area Served
Table 11. Manufacturers Diagnostic Radiopharmaceuticals & Contrast Media Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2018-2023) & (K Units)
Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2018-2023)
Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2018-2023)
Table 19. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2023) & (K Units)
Table 20. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2018-2023)
Table 21. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2018-2023)
Table 23. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2023) & (K Units)
Table 24. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2018-2023)
Table 25. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2018-2023)
Table 31. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2018-2023)
Table 33. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2018-2023)
Table 39. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2018-2023) & (K Units)
Table 40. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2018-2023)
Table 41. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Type (2018-2023)
Table 43. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Application (2018-2023)
Table 45. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2018-2023)
Table 46. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Application (2018-2023)
Table 48. Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2018-2023) & (USD/Unit)
Table 49. Amag Pharmaceuticals Corporation Information
Table 50. Amag Pharmaceuticals Description and Business Overview
Table 51. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 53. Amag Pharmaceuticals Recent Developments/Updates
Table 54. Bayer Healthcare Corporation Information
Table 55. Bayer Healthcare Description and Business Overview
Table 56. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 58. Bayer Healthcare Recent Developments/Updates
Table 59. Bracco Imaging Corporation Information
Table 60. Bracco Imaging Description and Business Overview
Table 61. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 63. Bracco Imaging Recent Developments/Updates
Table 64. Daiichi Sankyo Corporation Information
Table 65. Daiichi Sankyo Description and Business Overview
Table 66. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 67. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 68. Daiichi Sankyo Recent Developments/Updates
Table 69. GE Healthcare Corporation Information
Table 70. GE Healthcare Description and Business Overview
Table 71. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 72. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 73. GE Healthcare Recent Developments/Updates
Table 74. Guerbet Corporation Information
Table 75. Guerbet Description and Business Overview
Table 76. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 77. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 78. Guerbet Recent Developments/Updates
Table 79. Lantheus Corporation Information
Table 80. Lantheus Description and Business Overview
Table 81. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 83. Lantheus Recent Developments/Updates
Table 84. Mallinckrodt Corporation Information
Table 85. Mallinckrodt Description and Business Overview
Table 86. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 88. Mallinckrodt Recent Developments/Updates
Table 89. Medtronic Corporation Information
Table 90. Medtronic Description and Business Overview
Table 91. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 93. Medtronic Recent Developments/Updates
Table 94. Nordion Corporation Information
Table 95. Nordion Description and Business Overview
Table 96. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product
Table 98. Nordion Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
Table 102. Diagnostic Radiopharmaceuticals & Contrast Media Customers List
Table 103. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
Table 104. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
Table 105. Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
Table 106. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
Table 107. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Type (2023-2030) & (K Units)
Table 108. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Type (2023-2030)
Table 109. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 110. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Type (2023-2030)
Table 111. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Application (2023-2030) & (K Units)
Table 112. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Application (2023-2030)
Table 113. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 114. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Application (2023-2030)
Table 115. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Forecast by Region (2023-2030) & (K Units)
Table 116. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share Forecast by Region (2023-2030)
Table 117. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 118. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share Forecast by Region (2023-2030)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type in 2022 & 2030
Figure 3. Radiopharmaceuticals Product Picture
Figure 4. Contrast Media Product Picture
Figure 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application in 2022 & 2030
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue, (US$ Million), 2018 VS 2022 VS 2030
Figure 10. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2018-2030) & (US$ Million)
Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (2018-2030) & (K Units)
Figure 12. Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Manufacturers in 2022
Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers in 2022
Figure 14. The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players: Market Share by Revenue in 2022
Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2018-2023)
Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region in 2022
Figure 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2018-2023)
Figure 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region in 2022
Figure 20. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 21. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Vietnam Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. Sales Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2018-2023)
Figure 45. Manufacturing Cost Structure of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 46. Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals & Contrast Media
Figure 47. Diagnostic Radiopharmaceuticals & Contrast Media Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
